Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study

Krzysztof Mądry; Karol Lis; Przemysław Biecek; Magda Młynarczyk; Jagoda Rytel; Michał Górka; Piotr Kacprzyk; Magdalena Dutka; Marek Rodzaj; Łukasz Bołkun; Dorota Krochmalczyk; Ewa Łątka; Joanna Drozd-Sokołowska; Anna Waszczuk-Gajda; Wanda Knopińska-Posłuszny; Anna Kopińska; Edyta Subocz; Anna Masternak; Renata Guzicka-Kazimierczak; Lidia Gil; Rafał Machowicz; Jarosław Biliński; Sebastian Giebel; Tomasz Czerw; Jadwiga Dwilewicz-Trojaczek

doi:10.1016/j.clml.2019.01.002

Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.01.002 ◽

2019 ◽

Vol 19 (5) ◽

pp. 264-274.e4 ◽

Cited By ~ 1

Author(s):

Krzysztof Mądry ◽

Karol Lis ◽

Przemysław Biecek ◽

Magda Młynarczyk ◽

Jagoda Rytel ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Risk Model ◽

Infection Risk ◽

Chronic Myelomonocytic Leukemia ◽

Adult Leukemia ◽

Myelomonocytic Leukemia ◽

Leukemia Group ◽

Acute Myeloid

Dose-escalation Study of Oral Administration of LP-108 in Patients With Relapsed or Refractory Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)

Case Medical Research ◽

10.31525/ct1-nct04139434 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Oral Administration ◽

Dose Escalation ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Chronic Myelomonocytic Leukemia ◽

Dose Escalation Study ◽

Myelomonocytic Leukemia ◽

Acute Myeloid

A systematic review and meta-analysis of the efficacy and adverse events of azacitidine-plus-lenalidomide treatment for patients with acute myeloid leukemia, myelodysplastic syndromes and chronic myelomonocytic leukemia

Hematology ◽

10.1080/16078454.2019.1631425 ◽

2019 ◽

Vol 24 (1) ◽

pp. 498-506 ◽

Cited By ~ 1

Author(s):

Chutima Kunacheewa ◽

Pakaporn Thongthang ◽

Patompong Ungprasert ◽

Eakkapol Utchariyaprasit ◽

Weerapat Owattanapanich

Keyword(s):

Systematic Review ◽

Acute Myeloid Leukemia ◽

Adverse Events ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Meta Analysis ◽

Chronic Myelomonocytic Leukemia ◽

Myelomonocytic Leukemia ◽

Acute Myeloid

P-301 Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)

Leukemia Research ◽

10.1016/s0145-2126(13)70348-5 ◽

2013 ◽

Vol 37 ◽

pp. S157-S158

Author(s):

A. Freyrie ◽

G. Reda ◽

D. Vincenti ◽

V. Ferla ◽

N. Orofino ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Chronic Myelomonocytic Leukemia ◽

Myelomonocytic Leukemia ◽

Acute Myeloid

60 EXTENDED CC-486 (ORAL AZACITIDINE) DOSING IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), ACUTE MYELOID LEUKEMIA (AML), OR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): SAFETY, TOLERABILITY, AND RESPONSE

Leukemia Research ◽

10.1016/s0145-2126(15)30061-8 ◽

2015 ◽

Vol 39 ◽

pp. S29-S30

Author(s):

M.R. Savona ◽

K. Kolibaba ◽

P. Conkling ◽

E.C. Kingsley ◽

C. Becerra ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Chronic Myelomonocytic Leukemia ◽

Myelomonocytic Leukemia ◽

Acute Myeloid

A phase Ib study of oral panobinostat (LBH589) administered with 5-azacitidine (5-Aza) in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps282 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS282-TPS282

Author(s):

O. G. Ottmann ◽

P. Fenaux ◽

M. Lübbert ◽

D. J. DeAngelo ◽

G. Garcia-Manero ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Chronic Myelomonocytic Leukemia ◽

Phase Ib ◽

Myelomonocytic Leukemia ◽

Acute Myeloid

Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype

Cancer Genetics ◽

10.1016/j.cancergen.2016.05.072 ◽

2016 ◽

Vol 209 (7-8) ◽

pp. 313-320 ◽

Cited By ~ 15

Author(s):

Yang O. Huh ◽

Guilin Tang ◽

Sameer S. Talwalkar ◽

Joseph D. Khoury ◽

Maro Ohanian ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Chronic Myelomonocytic Leukemia ◽

Complex Karyotype ◽

Double Minute ◽

Myelomonocytic Leukemia ◽

Acute Myeloid ◽

Double Minute Chromosomes

AML-207: Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia: Effects on Marrow Recovery and Transfusion Independence

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(20)30733-3 ◽

2020 ◽

Vol 20 ◽

pp. S191-S192

Author(s):

Amer Zeidan ◽

Michael Schuster ◽

Magalie Joris ◽

Jürgen Krauter ◽

Johan Maertens ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Chronic Myelomonocytic Leukemia ◽

Transfusion Independence ◽

Myelomonocytic Leukemia ◽

Acute Myeloid

Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia

Current Medical Research and Opinion ◽

10.1185/03007995.2014.972499 ◽

2014 ◽

Vol 31 (1) ◽

pp. 35-42

Author(s):

S. Meers ◽

D. Selleslag ◽

H. Potier ◽

A. Glasmacher ◽

P. Mineur ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Chronic Myelomonocytic Leukemia ◽

Myelomonocytic Leukemia ◽

Access Program ◽

Acute Myeloid

A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

Journal of Patient-Reported Outcomes ◽

10.1186/s41687-019-0123-4 ◽

2019 ◽

Vol 3 (1) ◽

Cited By ~ 1

Author(s):

Jill A. Bell ◽

Aaron Galaznik ◽

Farrah Pompilus ◽

Sara Strzok ◽

Rafael Bejar ◽

...

Keyword(s):

Clinical Trials ◽

Acute Myeloid Leukemia ◽

Rare Disease ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Patient Reported Outcome ◽

Chronic Myelomonocytic Leukemia ◽

Patient Reported ◽

Myelomonocytic Leukemia ◽

Acute Myeloid

Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML)

Leukemia & Lymphoma ◽

10.1080/10428194.2016.1190971 ◽

2016 ◽

Vol 58 (2) ◽

pp. 298-307 ◽

Cited By ~ 5

Author(s):

Melita Kenealy ◽

Nigel Patton ◽

Robin Filshie ◽

Andrew Nicol ◽

Shir-Jing Ho ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Chronic Myelomonocytic Leukemia ◽

Blast Count ◽

Myelomonocytic Leukemia ◽

Acute Myeloid